The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology
Open accessAbstract
The field of metal-based anticancer drugs was initiated by cisplatin, one of the leading agents in clinical use. Cisplatin acts by binding to DNA and forming 1,2 intrastrand cross-links. Its importance is reflected by the fact that it is estimated that 50-70 % of cancer patients are treated with a platinum drug [7]. For some time, molecular designs in the metallo-drug field remained obdurately anchored in cis-diamine platinum(II) chemistry, but now the field is evolving rapidly with a variety of alternate and very diverse designs being explored. These designs give rise to new spectra of activity and potency and can circumvent cisplatin resistance. This critical review considers the existing clinical platinum drugs, and those currently in commercial development, alongside the new designs including ruthenium anticancer and antimetastatic drugs in clinical trials, polynuclear drugs, organometallic drugs, titanium and gallium drugs, and emerging supramolecular metallo-drugs that act on DNA by noncovalent interactions. The rapid evolution of the field is being informed by post-genomic knowledge and approaches, and further dramatic step-change breakthroughs can be expected as a result; harnessing this knowledge and responding to and taking advantage of this new environment requires integration of chemistry and biology research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Principles of bioinorganic chemistry
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4515 · Cited by 1,534
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Guo, Z., & Sadler, P. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1512::aid-anie1512>3.0.co;2-y · Cited by 834
Metal-based antitumour drugs in the post genomic era
Dyson, P. J., & Sava, G. (2006) · Dalton Transactions · doi:10.1039/b601840h · Cited by 771
Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995) · Nature · doi:10.1038/377649a0 · Cited by 769
Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Ang, W. H., & Dyson, P. J. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200600723 · Cited by 713
Improved understanding in platinium antitumour chemistry
Reedijk, J. (1996) · Chemical Communications · doi:10.1039/cc9960000801 · Cited by 589
Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin
Frederick, C. A., Williams, L. D., Ughetto, G., Van der Marel, G. A., Van Boom, J. H., Rich, A., & Wang, A. H. J. (1990) · Biochemistry · doi:10.1021/bi00462a016 · Cited by 578
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins
Ohndorf, U.-M., Rould, M. A., He, Q., Pabo, C. O., & Lippard, S. J. (1999) · Nature · doi:10.1038/21460 · Cited by 565
Ruthenium Antimetastatic Agents
Alessio, E., Mestroni, G., Bergamo, A., & Sava, G. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387421 · Cited by 479
Basis for Design and Development of Platinum(IV) Anticancer Complexes
Hall, M. D., Mellor, H. R., Callaghan, R., & Hambley, T. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070280u · Cited by 458
Rosenberg, B., Van Camp, L., Grimley, E. B., & Thomson, A. J. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96186-7 · Cited by 420
Supramolecular DNA recognition
Hannon, M. J. (2006) · Chemical Society Reviews · doi:10.1039/b606046n · Cited by 391
Self-citationDNA binding mode of ruthenium complexes and relationship to tumor cell toxicity
Brabec, V., & Nováková, O. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.002 · Cited by 384
DNA minor groove binders as potential antitumor and antimicrobial agents
Baraldi, P. G., Bovero, A., Fruttarolo, F., Preti, D., Tabrizi, M. A., Pavani, M. G., & Romagnoli, R. (2004) · Medicinal Research Reviews · doi:10.1002/med.20000 · Cited by 376
Guo, Z., & Sadler, P. J. (1999) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60271-8 · Cited by 354
Design of targeting ligands in medicinal inorganic chemistry
Storr, T., Thompson, K. H., & Orvig, C. (2006) · Chemical Society Reviews · doi:10.1039/b514859f · Cited by 326
Molecular Recognition of a Three‐Way DNA Junction by a Metallosupramolecular Helicate
Oleksy, A., Blanco, A. G., Boer, R., Usón, I., Aymamí, J., Rodger, A., Hannon, M. J., & Coll, M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503822 · Cited by 303
Self-citationMetal complexes in medicinal chemistry: new vistas and challenges in drug design
Thompson, K. H., & Orvig, C. (2006) · Dalton Trans. · doi:10.1039/b513476e · Cited by 298
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Antitumour Metallocenes: Structure-Activity Studies and Interactions with Biomolecules.
Harding, M., & Mokdsi, G. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374066 · Cited by 233
Holford, J., Sharp, S., Murrer, B., Abrams, M., & Kelland, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.59 · Cited by 196
Intramolecular DNA Coiling Mediated by a Metallo-Supramolecular Cylinder
Hannon, M. J., Moreno, V., Prieto, M. J., Moldrheim, E., Sletten, E., Meistermann, I., Isaac, C. J., Sanders, K. J., & Rodger, A. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010302)40:5<879::aid-anie879>3.0.co;2-x · Cited by 181
Self-citationVessières, A., Top, S., Beck, W., Hillard, E., & Jaouen, G. (2006) · Dalton Trans. · doi:10.1039/b509984f · Cited by 180
A Third Mode of DNA Binding: Phosphate Clamps by a Polynuclear Platinum Complex
Komeda, S., Moulaei, T., Woods, K. K., Chikuma, M., Farrell, N. P., & Williams, L. D. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062851y · Cited by 178
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Nováková, O., Kašpárková, J., Bursová, V., Hofr, C., Vojtíšková, M., Chen, H., Sadler, P. J., & Brabec, V. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.008 · Cited by 136
Jodrell, D. I., Evans, T. R. J., Steward, W. P., Cameron, D., Prendiville, J., Aschele, C., Noberasco, C., Lind, M., Carmichael, J., Dobbs, N. A., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.032 · Cited by 130
Cerasino, L., Hannon, M. J., & Sletten, E. (2007) · Inorganic Chemistry · doi:10.1021/ic062415c · Cited by 80
Self-citationBifunctional transition metal complexes as nucleic acid photoprobes and photoreagents
Pierard, F., & Mesmaeker, A. K. (2005) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2005.10.016 · Cited by 55
Synthesis, Anticancer and Antibacterial Activity of Some Novel Mononuclear Ru(II) Complexes
Mazumder, U. K., Gupta, M., Karki, S. S., Bhattacharya, S., Rathinasamy, S., & Thangavel, S. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.178 · Cited by 52
Perron, V., Rabouin, D., Asselin, É., Parent, S., Gaudreault, R. C., & Bérubé, G. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.06.009 · Cited by 50
Beale, P. J., Judson, I. R., O’Donnell, A. E., Trigo, J. M., Rees, C., Raynaud, F. I., Turner, A., Simmons, L., & Etterley, L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600854 · Cited by 43
Cited by
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 527
Metal complex interactions with DNA
Pages, B. J., Ang, D. L., Wright, E. P., & Aldrich-Wright, J. R. (2015) · Dalton Transactions · doi:10.1039/c4dt02700k · Cited by 459
Metadata
- Authors
- Hannon, M. J.
- Venue
- Pure and Applied Chemistry
- Publisher
- Walter de Gruyter GmbH
- Published
- 2007-01-01
- Volume
- 79
- Issue
- 12
- Pages
- 2243-2261
- ISSN
- 0033-4545 (ISSN-L)
- 1365-3075
- OpenAlex
- W2117041045
- Cited by
- 313
- References
- 35
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.